Breast cancer risk assessment in the Czech female population - An adjustment of the original Gail model

Breast Cancer Research and Treatment

Volumn 95, Issue 1, 2006, Pages 29-35

  Novotny, Jan ^a   Pecen, Ladislav ^b   Petruzelka, Lubos ^a   Svobodnik, Adam ^c   Dusek, Ladislav ^c   Danes, Jan ^a   Skovajsova, Miloslava ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d Diagnostic and Therapeutic Centre   (Czech Republic)

Author keywords

Breast cancer; Gail model; Risk assessment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; HUMAN; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCHOOL CHILD; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CZECH REPUBLIC; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; RISK ASSESSMENT;

EID: 32444438935     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9027-5     Document Type: Article

References (11)

1. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C: Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 14: 490-495, 2003
2. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH: Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95: 526-532, 2003
3. Armstrong K, Eisen A, Weber B: Assessing the risk of breast cancer. N Engl J Med 342: 564-571, 2000
4. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886, 1989
5. Newman LA, Gail MH, Selvan M, Bondy M, Rockhill B, Colditz G et al.: Proposed revision of the Gail breast cancer (BC) risk assessment model. Proc Am Soc Clin Oncol 22: 845, 2003abstract 3396
6. Constantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J et al.: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91: 1541-1548, 1999
7. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL: Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21: 593-601, 2003
8. Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, et al.: Overview of the main outcomes in breast-cancer prevention trials. Lancet 361: 296-300, 2003
9. Fisher B, Constantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al.: Tamoxifen for prevention of breast cancer: a report of the National Surgical Adjuvant Breast Bowel Project P-1. J Natl Cancer Inst 90: 1371-1388, 1998
10. Wickerham DL: Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial. Recent Results Cancer Res. 163: 87-95, 2003
11. Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5. IARC Press, Lyon, 2001